TofuraUllahMD

Clinical Trials

• ACTIV-2: A Study for Outpatients With COVID-19 Start of enrollment: 2020 Aug 19

  Completed

  Phase 2, Phase 3

• Immune Modulators for Treating COVID-19 Start of enrollment: 2020 Oct 15

  Completed

  Phase 3

• Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia Start of enrollment: 2022 Apr 26

  Recruiting

  Phase 1, Phase 2

• A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. Start of enrollment: 2021 Oct 20

  Terminated

  Phase 2

• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis Start of enrollment: 2021 Feb 15

  Completed

  Phase 3

• Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 Start of enrollment: 2020 Oct 21

  Terminated

  Phase 2

• Ruxolitinib in the Treatment of Covid-19 Start of enrollment: 2020 Jun 01

  Not yet recruiting

  Phase 2

• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) Start of enrollment: 2020 Apr 15

  Completed

  Phase 2

• Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19 Start of enrollment: 2021 Jun 01

  Recruiting

• A Trial of Remdesivir in Adults With Severe COVID-19 Start of enrollment: 2020 Feb 06

  Terminated

  Phase 3

• A Trial of Remdesivir in Adults With Mild and Moderate COVID-19 Start of enrollment: 2020 Feb 12

  Suspended

  Phase 3

• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Start of enrollment: 2018 Feb 09

  Active, not recruiting

  Phase 4

• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2018 Jul 16

  Completed

  Phase 2

• Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes Start of enrollment: 2016 Mar 01

  Completed

  Phase 3

• A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Start of enrollment: 2014 Jan 07

  Completed

  Phase 3

• PATHFINDER 2: A Multi-Cancer Early Detection Study Start of enrollment: 2021 Dec 08

  Recruiting

  Not Applicable

• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome Start of enrollment: 2021 Jun 24

  Active, not recruiting

  Phase 3

• Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke Start of enrollment: 2022 Sep 14

  Recruiting

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome Start of enrollment: 2023 Apr 07

  Recruiting

  Phase 3

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE Start of enrollment: 2023 Feb 15

  Recruiting

  Phase 3

• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation Start of enrollment: 2023 Apr 11

  Recruiting

  Phase 3

• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) Start of enrollment: 2023 Mar 28

  Recruiting

  Phase 3

• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD Start of enrollment: 2024 May 27

  Not yet recruiting

  Phase 3

• Dual Implant Versus Single Implant Distal End of Femur Start of enrollment: 2022 Feb 10

  Enrolling by invitation

  Not Applicable

• Join now to see all